Novel tripeptide RKH derived from Akkermansia muciniphila protects against lethal sepsis.
Gut(2023)
Abstract
We revealed that a novel tripeptide, RKH, derived from live AKK, may act as a novel endogenous antagonist for TLR4. RKH may serve as a novel potential therapeutic approach to combat lethal sepsis after successfully translating its efficacy into clinical practice.
MoreTranslated text
Key words
sepsis, probiotics, macrophages, inflammation, intestinal microbiology
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined